Sales & Marketing

The acquisition by ILSL Inc., a subsidiary of Indegene Private Limited, augments Indegene’s commercialization portfolio spanning drug discovery and development to marketing and sales, adding brand strategy, market development capabilities, and patient engagement platforms.

Two additional leadership moves also strengthen management team.

Pharmaceutical Executive presents the 2022 APEX Awards, which is presented by a jury of HCPs for breakthroughs in pharmaceutical and healthcare marketing and communications.

Elevalt’s 4Ps proprietary algorithms are the culmination of 6 years of refining omnichannel execution and are the foundation of the company’s data-driven approach to commercialization.

Follows recent launch of DeepIntent's innovative "Patient Planner" to simplify audience creation and campaign activation.

There has been a push to implement NFTs, or non-fungible tokens, across many verticals, but there is still much to learn about their potential uses in healthcare and its brands.

New managing director Trevor Pill has been passed the company's helm from founder Karen Winterhalter.

The highly-regulated pharmaceutical industry poses serious challenges that can derail digital health programs. But, there are solutions.

Leo Tarkovsky brings more than 25 years of proven experience scaling companies in the healthcare space.

Under its Commercial License Agreement with OBT, Genmab will obtain the exclusive right to develop and commercialize novel antibody therapeutics utilizing OBT's novel, first-in-class IO antibody.

Fast-growing specialty pharma selects Veeva CRM and Veeva Vault PromoMats to build a unified foundation for commercial excellence.

Should pharma brands still maintain dedicated websites to engage HCPs? Are they effective and trustworthy sources of information that offer intuitive and helpful experiences for the user?

Created in response to emerging consumer trends and behaviors, these innovations support efforts to bridge gaps between people and quality care.

Heim is an accomplished business leader with strong leadership experience, and an established reputation within Pharmaceutical, Medical Device and Health Technology markets.

Award-winning healthcare IT PR agency and care operations automation leaders partner to bring world-class operations to health systems.

Lasso and CMI Media Group are the first to successfully leverage IBM Watson's dynamic creative capabilities for healthcare marketing, driving media performance 40% above benchmark.

Brand Institute, the naming agency, is proud to celebrate the 20-year anniversary of the company's expansion into Europe

Award-winning healthcare IT marketing & PR agency to collaborate with leader in data and analytics software solutions and services.

A cookieless future is on the horizon, so marketers across all industries are being forced to rethink their strategies and plan for the future. What does that entail?

Rohit Gupta is vice president of analytics strategy and transformation at Beghou Consulting - he works with biopharma leaders on all facets of drug commercialization, from market sizing strategies, to launch planning, to business analytics.

The integration of the "Amplion knowledgebase" and next-generation data architecture will immediately expand Science & Medicine Group's capabilities to deliver more comprehensive, actionable insights to commercial organizations at life science equipment and reagent manufacturers as well as pharmaceutical services providers.

The new office officially opened on September 8, and will enhance the firm's ability to serve clients in Boston and the surrounding area.

Senior leaders in pharma, healthcare marketing and communications, and advertising got together to discuss the progress and lingering roadblocks in advancing diversity, equity, and inclusion strategies in the life sciences—where the common thread seems clear: the messenger matters.

A fresh look at how industry benchmarks can help fortify new drug launches to overcome today’s new market-entry barriers and higher expectations.

Launch of novel drug for rare neuromuscular disorder seeks to give voice to the patients.

Use against pair of pathways could pave way for standout in stocked eye disease market.

Tapping the potential of new market mindset in insomnia—delivering a quality next day.

Dual-targeted injection poised to rock GLP-1 field in diabetes—and eventually weight loss.

More favorable administration, reimbursement could separate latest PCSK9 entrant.

What the rising rate of physician-hospital affiliations means for pharma.